Effects of possible endocrine disrupting chemicals on bacterial component-induced activation of NF-κB

Biological and Pharmaceutical Bulletin

Volumn 29, Issue 10, 2006, Pages 2120-2122

  Igarashi, Arisa ^a   Ohtsu, Satoko ^a   Muroi, Masashi ^a   Tanamoto, Ken Ichi ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Bacterial lipoprotein; Endocrine disruptor; Lipopolysaccharide; Macrophage; Nuclear factor kappa B (NF B)

Indexed keywords

2,4 DICHLOROPHENOL; 2,4 DICHLOROPHENOXYACETIC ACID; 4 NITROTOLUENE; 4 OCTYLPHENOL; 4,4' ISOPROPYLIDENEDIPHENOL; ALACHLOR; ALDICARB; AMITROLE; ATRAZINE; BACTERIUM LIPOPOLYSACCHARIDE; BENOMYL; BENZOPHENONE; CARBARIL; CHLORDECONE; DICOFOL; ENDOCRINE DISRUPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPEPTIDE; MALATHION; METHOMYL; METHOXYCHLOR; METRIBUZIN; NONYLPHENOL; OCTACHLOROSTYRENE; PENTACHLOROPHENOL; PHTHALIC ACID BENZYL BUTYL ESTER; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; PHTHALIC ACID DIBUTYL ESTER; SIMAZINE; UNCLASSIFIED DRUG; ZIRAM;

ANIMAL CELL; ARTICLE; BACTERIAL INFECTION; CELL LINE; CONTROLLED STUDY; DISEASE EXACERBATION; IMMUNE SYSTEM; INNATE IMMUNITY; MACROPHAGE FUNCTION; MOUSE; NONHUMAN; REPORTER GENE;

ANIMALS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCRINE DISRUPTORS; LIPOPEPTIDES; LIPOPOLYSACCHARIDES; MICE; NF-KAPPA B; PEPTIDES;

EID: 33749434070     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.29.2120     Document Type: Article

References (12)

1. Safe S., Wang F., Porter W., Duan R., McDougal A., Toxicol. Lett., 102-103, 343-347 (1998).
2. Schrenk D., Biochem. Pharmacol., 55, 1155-1162 (1998).
3. Eskenazi B., Mocarelli P., Warner M., Samuels S., Vercellini P., Olive D., Needham L., Patterson D., Brambilla P., Chemosphere, 40, 1247-1253 (2000).
4. Masuyama H., Hiramatsu Y., Kunitomi M., Kudo T., MacDonald P. N., Mol. Endocrinol., 14, 421-428 (2000).
5. Inoshita H., Masuyama H., Hiramatsu Y., J. Mol. Endocrinol., 31, 551-561 (2003).
6. Fujihara M., Muroi M., Tanamoto K., Suzuki T., Azuma H., Ikeda H., Pharmacol. Ther., 100, 171-194 (2003).
7. Hong C. C., Shimomura-Shimizu M., Muroi M., Tanamoto K., Biol. Pharm. Bull., 27, 1136-1139 (2004).
8. Muroi M., Ohnishi T., Tanamoto K., J. Biol. Chem., 277, 42372-42379 (2002).
9. Ohnishi T., Muroi M., Tanamoto K., J. Immunol., 167, 3354-3359 (2001).
10. Muroi M., Tanamoto K., J. Biol. Chem., 281, 5484-5491 (2006).
11. Shimomura-Shimizu M., Sugiyama K., Muroi M., Tanamoto K., Biochem. Biophys. Res. Commun., 332, 793-799 (2005).
12. Corsini E., Viviani B., Birindelli S., Gilardi F., Torri A., Codeca I., Lucchi L., Bartesaghi S., Galli C. L., Marinovich M., Colosio C., Toxicol. Appl. Pharmacol., 212, 89-98 (2006).